In-depth training on the latest advancements in breast cancer management for young medical oncologists and advanced trainees
Friday 31 October - Saturday 1 November 2025
Venue: Cliftons Sydney Margaret Street
Level 13, 60 Margaret Street, Sydney NSW 2000
Co-Convenors: A/Prof Connie Diakos and Dr Lina Pugliano
MOGA Breast Cancer Preceptorship 2025
Program:
The MOGA breast cancer preceptorship aims to immerse advanced trainees and fellows in the evolving landscape of breast cancer treatment by providing an in-depth exploration of the pivotal clinical trials conducted over the past decade. Participants will delve into landmark studies, including those leading to the approval of CDK4/6 inhibitors, PARP inhibitors, and HER2-targeted therapies, examining their design, methodologies, and outcomes. The program will encourage critical analysis of these trials, assessing their impact on clinical practice, advancements in personalised medicine, and improvements in patient outcomes. By critiquing these studies, trainees will develop a nuanced understanding of evidence-based treatment strategies and the complexities involved in translating clinical research into routine care, ultimately enhancing their ability to contribute to future innovations in breast cancer therapy.
Learning Objectives:
1. Deepen understanding of contemporary breast cancer clinical trials to enhance holistic and optimised treatment of patients with breast cancer
2. Development of critical thinking through appraisal of research studies, assessing their validity, relevance, and applicability to clinical practice
3. Develop appreciation of the role of multidisciplinary care in the management of patients with breast cancer
The program will comprise presentations by Preceptees, lectures and discussions over 1.5 days. Preceptees will propose a paper for presentation as part of their registration and also be allocated cases to present. Presentations will run for approximately 10 minutes followed by discussion. Preceptors will assist their allocated Preceptees with their presentations as part of the Preceptorship.
Target Audience:
Up to 35 young medical oncologists (within 5 years of receipt of fellowship) and Advanced Trainees from around Australia will be invited to register as Preceptees for the program. Up to 12 early to mid-career medical oncologists with breast experience will be invited to participate in the program as Preceptors.
Application Process:
Application will be open to MOGA Members. A refundable fee of $150.00 will be charged on registration to secure your place in the preceptorship.
Participants will be provided with registration, all course materials and day catering including a Networking Event. Support for travel and accommodation will be available for interstate and regional participants.
Program*
Day 1
8:00am Registration
8:30am Welcome
8:35am Session 1: Neoadjuvant HR+, TNBC, HER2+
9:50am Sponsor Presentation by Astra Zeneca/Daiichi-Sankyo
10:00am Morning Tea
10:15am Session 2: Case Presentations 1
11:30am Session 3: Adjuvant HR+, TNBC, HER2+
12:45pm Lunch
1:30pm Session 4: Case Presentations 2
2:45pm Afternoon Tea
3:00pm Sponsor Presentation by Novartis
3:10pm Session 5: Careers
3.40pm Session 6: Metastatic HR+, TNBC
5:00pm Networking Event
Day 2
8:30am Welcome
8:35am Session 7: Metastatic HER2+, HER2 Low
9:50am Sponsor Presentation by Pfizer Oncology
10:00am Morning Tea
10:30am Session 8: Case Presentations 3
12:00pm Workshop Concludes
*Program subject to change
Join today and take advantage of members’ only benefits.
meet your PRECEPTORS
-
![]()
Dr Tristan Barnes
Medical Oncologist, GenesisCare
-
![]()
Dr Tam Bui
Medical Oncologist, Concord Cancer Centre
-
![]()
Jenny Gilchrist
Nurse Practitioner - Breast Oncology, Macquarie University
-
![]()
A/Prof Mahesh Iddawela
Medical Oncologist, Peninsula Health, Monash University
-
![]()
Dr Cristina Mapagu
Staff Specialist Medical Oncology, Nepean Hospital
-
Dr Hilary Martin
Medical Oncologist, Fiona Stanley Hospital
-
![]()
Dr Kazi Nahar
Medical Oncologist, Sydney Adventist Hospital
-
![]()
Dr John Park
Medical Oncologist, Nepean Cancer Care Centre
-
![]()
Dr Andrew Parsonson
Medical Oncologist, Macquarie University
-
Dr Antonia Pearson
Medical Oncologist, Northern Beaches Hospital, Genesis Care
-
![]()
Dr Dhanusha Sabanathan
Medical Oncologist, Macquarie University
-
![]()
Dr Iris Tung
Medical Oncologist, Eastern Health
EXPRESSIONS OF INTEREST ARE NOW CLOSED
Call for Expressions of Interest –
Preceptors for MOGA Breast Cancer Preceptorship 2025
MOGA is seeking Expressions of Interest (EOI) from early to mid-career medical oncologists interested in volunteering to be Preceptors for the MOGA Breast Cancer Preceptorship 2025. The Preceptorship will take place for 1.5 days on Friday, 31 October - Saturday, 1 November 2025 in Sydney.
The Preceptorship will be convened by A/Prof Connie Diakos and Dr Lina Pugliano.
The program will comprise presentations by up to 35 Preceptees and a networking reception. Preceptors will assist 1 – 2 Preceptees with their presentations as part of the Preceptorship. Registration, accommodation and travel support will be provided.
Medical oncologists with expertise in breast cancer from across Australia are invited to submit an Expression of Interest (EOI).
To apply, please complete the online EOI form via the link below by COB Friday, 29 August 2025. Your submission should include a brief supporting statement and a copy of your CV.
If you have any questions about the role, please don’t hesitate to get in touch via moga@moga.org.au
